Phase II clinical trial of the superiority of montelukastine in combination with TPO-MPL agonists for the treament of primary immune thrombocytopenia Phase II clinical trial of the superiority of montelukastine in combination with TPO-MPL agonists fo ...
Phase II clinical trial of the superiority of montelukastine in combination with TPO-MPL agonists for the treament of primary immune thrombocytopenia Phase II clinical trial of the superiority of montelukastine in combination with TPO-MPL agonists fo ...